Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China
Description
INTRODUCTION: The slow descent in TB burden, the COVID-19 pandemic, along with the rise of multidrug-resistant strains of Mycobacterium tuberculosis, seriously threaten TB control and the goals of the End TB strategy. To fight back, several vaccine
